A novel CDKL5 mutation in a Japanese patient with atypical Rett syndrome.
Rett syndrome (RTT) is a severe X-linked dominant inheritance disorder with a wide spectrum of clinical manifestations. Mutations in Methyl CpG binding protein 2 (MECP2), Cyclin dependent kinase-like 5 (CDKL5) and Forkhead box G1 (FOXG1) have been associated with classic and/or variant RTT. This study was conducted to identify the responsible gene(s) in atypical RTT patient, and to examine the effect of the mutation on protein function. DNA sequence analysis showed a novel heterozygous mutation in CDKL5 identified as c.530A>G which resulted in an amino acid substitution at position 177, from tyrosine to cysteine. Genotyping analysis indicated that the mutation was not merely a single nucleotide polymorphism (SNP). We also revealed that patient's blood lymphocytes had random X-chromosome inactivation (XCI) pattern. Further examination by bioinformatics analysis demonstrated the mutation caused damage or deleterious in its protein. In addition, we demonstrated in vitro kinase assay of mutant protein showed impairment of its activity. Taken together, the results suggested the mutant CDKL5 was responsible for the disease.
['Christianto|Antonius|A|', 'Katayama|Syouichi|S|', 'Kameshita|Isamu|I|', 'Inazu|Tetsuya|T|']
D005260:Female D006801:Humans D007564:Japan D008875:Middle Aged D009154:Mutation D017346:Protein Serine-Threonine Kinases D015518:Rett Syndrome
In vitro kinase assay Cyclin dependent kinase-like 5 gene Novel missense mutation